COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
LINC01672 |
|
long intergenic non-protein coding RNA 1672
|
|
|
0.462 |
0.846 |
MS |
|
multiple sclerosis
|
|
|
0.599 |
0.692 |
OPN1MW3 |
P04001 P0DN77 P0DN78
|
opsin 1, medium wave sensitive 3
|
|
|
0.601 |
0.769 |
MAP3K14 |
Q99558
|
mitogen-activated protein kinase kinase kinase 14
|
Kinase
|
|
0.608 |
0.769 |
PSS |
|
Potocki-Shaffer syndrome
|
|
|
0.608 |
0.654 |
SMIM10L2A |
P0DMW4 P0DMW5
|
small integral membrane protein 10 like 2A
|
|
|
0.619 |
0.808 |
SMIM10L2B |
P0DMW4 P0DMW5
|
small integral membrane protein 10 like 2B
|
|
|
0.619 |
0.808 |
HCA1 |
|
Hypercalciuria, absorptive, 1
|
|
|
0.633 |
0.654 |
PRKACG |
P22612
|
protein kinase cAMP-activated catalytic subunit gamma
|
Kinase
|
|
0.644 |
0.654 |
TEC |
|
transient erythroblastopenia of childhood
|
|
|
0.659 |
0.577 |
BAS |
|
Beta-adrenergic stimulation, response to
|
|
|
0.711 |
0.346 |
GULOP |
|
gulonolactone (L-) oxidase, pseudogene
|
|
|
0.805 |
0.308 |
CFTR |
P13569
|
CF transmembrane conductance regulator
|
Ion channel
|
2.2E-58 |
0.424 |
0.885 |
ACE |
P12821
|
angiotensin I converting enzyme
|
Enzyme
|
1.0E-37 |
0.328 |
0.923 |
NOC2L |
Q9Y3T9
|
NOC2 like nucleolar associated transcriptional repressor
|
|
2.9E-29 |
0.593 |
0.731 |
IFT122 |
Q9HBG6
|
intraflagellar transport 122
|
|
2.4E-24 |
0.560 |
0.846 |
SYNM |
O15061
|
synemin
|
|
3.0E-24 |
0.575 |
0.731 |
INSRR |
P14616
|
insulin receptor related receptor
|
Kinase
|
5.4E-24 |
0.508 |
0.808 |
TLR1 |
Q15399
|
toll like receptor 1
|
|
5.9E-23 |
0.496 |
0.808 |
CDK15 |
Q96Q40
|
cyclin dependent kinase 15
|
Kinase
|
2.2E-17 |
0.663 |
0.500 |
PCSK9 |
Q8NBP7
|
proprotein convertase subtilisin/kexin type 9
|
Enzyme
|
2.7E-17 |
0.482 |
0.808 |
ALLC |
Q8N6M5
|
allantoicase
|
|
4.2E-16 |
0.695 |
0.385 |
CAMKMT |
Q7Z624
|
calmodulin-lysine N-methyltransferase
|
|
1.4E-15 |
0.510 |
0.808 |
FDFT1 |
P37268
|
farnesyl-diphosphate farnesyltransferase 1
|
|
4.1E-15 |
0.621 |
0.615 |